🔗 Share this article

This year's prestigious award in medical science has been granted for revolutionary findings that illuminate how the immune system attacks dangerous infections while protecting the body's own cells.

A trio of esteemed scientists—Japan's Prof. Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—received this accolade.

Their research identified unique "sentinels" within the defense system that remove malfunctioning defense cells capable of attacking the body.

These discoveries are now paving the way for new therapies for autoimmune diseases and malignancies.

These winners will share a prize fund valued at 11 million SEK.

Decisive Findings

"Their research has been essential for comprehending how the immune system operates and why we do not all suffer from serious self-attack conditions," stated the chair of the Nobel Committee.

This team's studies explain a fundamental mystery: How does the defense system defend us from countless infections while leaving our own tissues unharmed?

The immune system employs immune cells that search for signs of infection, including viruses and bacteria it has never encountered.

Such cells utilize detectors—known as receptors—that are produced by chance in a vast number of combinations.

That gives the immune system the capacity to combat a broad range of invaders, but the randomness of the mechanism unavoidably produces white blood cells that may attack the host.

Protectors of the Body

Scientists previously knew that a portion of these problematic defense cells were destroyed in the thymus—where white blood cells develop.

The latest award honors the discovery of T-reg cells—known as the immune system's "peacekeepers"—which patrol the system to neutralize any immune cells that assault the healthy cells.

It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A prize committee stated, "These findings have laid the foundation for a new field of research and spurred the creation of new therapies, for example for cancer and autoimmune diseases."

In malignancies, T-regs block the body from fighting the tumor, so research are focused on reducing their quantity.

In self-attack disorders, trials are testing boosting regulatory T-cells so the organism is no longer being harmed. A similar approach could also be useful in reducing the risks of organ transplant failure.

Innovative Experiments

Professor Sakaguchi, from a Japanese institution, conducted tests on mice that had their immune gland removed, leading to self-attack conditions.

The researcher demonstrated that introducing immune cells from healthy mice could stop the illness—implying there was a mechanism for preventing defenders from harming the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an inherited autoimmune disease in mice and humans that resulted in the identification of a gene vital for the way T-regs function.

"Their pioneering research has uncovered how the immune system is controlled by regulatory T cells, preventing it from accidentally attacking the body's own tissues," commented a prominent biological science specialist.

"This work is a striking example of how fundamental physiological research can have far-reaching implications for public health."